[1]
“Assessment of HER2/neu among Female with Invasive Ductal Breast Carcinoma, Using Manual Tissue Microarray Technology in Khartoum State, Sudan”, EJBIOMED, vol. 1, no. 4, pp. 10–13, Aug. 2022, doi: 10.24018/ejbiomed.2022.1.4.20.